BNP Paribas Financial Markets
FHTX icon

BNP Paribas Financial Markets’s Foghorn Therapeutics FHTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.4K Buy
12,849
+4,576
+55% +$25.1K ﹤0.01% 4591
2025
Q4 		$44.7K Buy
8,273
+1,170
+16% +$5.3K ﹤0.01% 4737
2025
Q3 		$34.7K Buy
7,103
+2,305
+48% +$12.2K ﹤0.01% 4744
2025
Q2 		$22.6K Buy
4,798
+1,632
+52% +$6.82K ﹤0.01% 4544
2025
Q1 		$11.6K Sell
3,166
-9,780
-76% -$44.6K ﹤0.01% 4685
2024
Q4 		$61.1K Buy
+12,946
New +$94.3K ﹤0.01% 4344
2022
Q4 		– Sell
-10,707
Closed -$91.9K – 4238
2022
Q3 		$91.9K Buy
+10,707
New +$138K ﹤0.01% 3812

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

BNP Paribas Financial Markets's FHTX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Foghorn Therapeutics (FHTX) stake by 55% in Q1 2026, buying an estimated $25.1K and bringing the position to 12,849 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4591.

BNP Paribas Financial Markets first reported a position in FHTX in Q3 2022 and has held it in 7 quarters since. The position peaked at $91.9K in Q3 2022. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • BNP Paribas Financial Markets held 12,849 shares of Foghorn Therapeutics worth $61.4K as of Q1 2026.
  • BNP Paribas Financial Markets bought 4,576 Foghorn Therapeutics shares in Q1 2026, an estimated $25.1K.
  • Foghorn Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4591 holding.
  • BNP Paribas Financial Markets first reported a position in Foghorn Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Foghorn Therapeutics position peaked at $91.9K in Q3 2022.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.